James Steven P

CIK 00012430254 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001243025

Recent Transactions

47 trades

Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−16,000→ 0 total
Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−18,800→ 0 total
Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−55,380→ 0 total
Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−41,000→ 0 total
Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−86,762→ 0 total
Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−99,590→ 0 total
Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−7,700→ 0 total
Disposition to Issuer
Allakos Inc.
Stock Option (right to buy)
2025-05-15−7,700→ 0 total
Award
Allakos Inc.
Stock Option (Right to buy)
2024-05-24+41,000→ 41,000 total
Award
Allakos Inc.
Stock Option (Right to buy)
2023-05-25+86,762→ 86,762 total
Award
Allakos Inc.
Stock Option (Right to buy)
2022-05-25+99,590→ 99,590 total
Sale
Allakos Inc.
Common Stock
2021-09-28$108.12/sh−4,000→ 0 total
Exercise/Conversion
Allakos Inc.
Stock Option (Right to buy)
2021-09-28−4,000→ 55,380 total
Exercise/Conversion
Allakos Inc.
Common Stock
2021-09-28$0.53/sh+4,000→ 4,000 total
Award
Allakos Inc.
Stock Option (Right to buy)
2021-05-25+7,700→ 7,700 total
Exercise/Conversion
Allakos Inc.
Stock Option (Right to buy)
2021-03-16−3,500→ 59,380 total
Exercise/Conversion
Allakos Inc.
Common Stock
2021-03-16$0.53/sh+3,500→ 3,500 total
Sale
Allakos Inc.
Common Stock
2021-03-16$121.65/sh−3,500→ 0 total
Award
Allakos Inc.
Stock Option (Right to Buy)
2020-05-26+7,700→ 7,700 total
Award
Allakos Inc.
Stock Option (Right to Buy)
2019-06-06+16,000→ 16,000 total
Disposition from Tender
Cascadian Therapeutics, Inc.
Common Stock
2018-03-09−13,677→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−13,927→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−20,000→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−10,000→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−12,500→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Common Stock
2017-12-11$1.52/sh−12,500→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2017-09-24+2,375→ 14,271 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-09-24−2,375→ 0 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2017-09-24$3.94/sh−594→ 13,677 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2017-06-24+9,058→ 14,161 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2017-06-24$3.78/sh−2,265→ 11,896 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-06-24−9,058→ 0 total
Award
Ocera Therapeutics, Inc.
Common Stock
2017-06-20+12,500→ 12,500 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2017-06-12$3.34/sh−537→ 5,103 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-06-12−2,148→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2017-06-12+2,148→ 5,640 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-06-09+13,927→ 13,927 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-03-12−4,656→ 0 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2017-03-12+4,656→ 4,656 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2017-03-12$4.35/sh−1,164→ 3,492 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2016-06-24+54,347→ 54,347 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-06-14+12,500→ 12,500 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2015-09-24+14,245→ 14,245 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2015-06-18+10,000→ 10,000 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2015-06-12+12,886→ 12,886 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2015-03-12+27,932→ 27,932 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2014-09-17+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610

PALO ALTO, CA, 94301

View on SEC.gov